Daniel B. Dubin, MD Joins NanoBio Corp.’s Board of Directors

ANN ARBOR, Mich. (7/8/2008)-NanoBio® Corp., a biopharmaceutical company focused on developing and commercializing novel products to prevent and treat infectious diseases, today announced the appointment of Dr. Daniel B. Dubin to its board of directors.
Dr. Dubin currently serves as Vice Chairman and a Director at Leerink Swann, a leading healthcare and biotechnology investment banking firm.
“Dan’s [.. more ..]

Who links to my website?